Skip to main content
. 2017 May 24;47(9):832–839. doi: 10.1093/jjco/hyx075

Table 3.

Incidence of prespecified ADRs by grade (n = 843)

ADR, n (%) Grade 1 Grade 2 Grade 3 Grade 4 Grade 5 Total
ILD (IRC confirmed) 19 (2.3) 13 (1.5) 17 (2.0) 1 (0.1) 2 (0.2) 52 (6.2)
Skin disorders 309 (36.7) 234 (27.8) 44 (5.2) 1 (0.1) 0 (0.0) 589 (69.9)
 Rash 304 (36.1) 197 (23.4) 34 (4.0) 0 (0.0) 0 (0.0) 536 (63.6)
 Dry skin 38 (4.5) 12 (1.4) 1 (0.1) 0 (0.0) 0 (0.0) 51 (6.0)
 Pruritus 20 (2.4) 5 (0.6) 0 (0.0) 0 (0.0) 0 (0.0) 25 (2.9)
 Paronychia 38 (4.5) 45 (5.3) 7 (0.8) 0 (0.0) 0 (0.0) 90 (10.7)
Liver disorder 41 (4.9) 33 (3.9) 31 (3.7) 2 (0.2) 0 (0.0) 107 (12.7)
Diarrhea 85 (10.8) 49 (5.8) 13 (1.5) 2 (0.2) 0 (0.0) 148 (17.6)
Eye disorders 12 (1.4) 3 (0.4) 0 (0.0) 0 (0.0) 0 (0.0) 15 (1.8)
Hemorrhage 23 (2.7) 4 (0.5) 9 (1.1) 2 (0.2) 4 (0.5) 42 (5.0)
Thrombotic microangiopathy 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Myocardial infarction 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Cerebral disorders 1 (0.1) 1 (0.1) 1 (0.1) 0 (0.0) 2 (0.2) 5 (0.6)
Gastrointestinal perforation 0 (0.0) 1 (0.1) 1 (0.1) 0 (0.0) 0 (0.0) 2 (0.2)
Gastrointestinal ulcer 1 (0.1) 4 (0.5) 4 (0.5) 0 (0.0) 0 (0.0) 9 (1.1)
Renal failure 0 (0.0) 0 (0.0) 1 (0.1) 0 (0.0) 0 (0.0) 1 (0.1)